Perceptronix to Exhibit at Toronto Academy of Dentistry Annual Winter Clinic
Posted on: Thursday, 13 November 2008, 18:00 CST
Perceptronix Medical Inc., an independent quantitative cytology laboratory specializing in early cancer detection tests, will be exhibiting at the Toronto Academy of Dentistry's 71st Annual Winter Clinic on November 14, 2008 at the Metro Toronto Convention Centre. Perceptronix will be showcasing OralAdvance(TM), a new quantitative cytology test for the early detection of oral cancer, and demonstrating its use at booth 1112.
With recent advances in visualization techniques for the oral cavity, dentists are encountering more suspicious lesions. OralAdvance(TM), with its soft cyto-brush sample collection kit, provides dentists with an informative new option for assessing these lesions when biopsy is not warranted or possible. It provides an objective measure of gross DNA abnormality that can give additional information about the pre-malignant or malignant nature of a lesion.
About Perceptronix Medical Inc.
Perceptronix Medical Inc. (Vancouver, Canada) is a private laboratory and cancer diagnostics company specializing in the provision of innovative early cancer detection tests based on quantitative cytology. The Company's DNA image cytometry technology was developed in partnership with the British Columbia Cancer Agency (Vancouver, Canada). Quantitative cytology provides physicians with an innovative cytopathology assessment based on an objective measure of large-scale DNA abnormality that can indicate precancerous or cancerous changes. In addition to general quantitative cytology services, the company has developed innovative tests for the early detection of lung cancer and oral cancer.
Contacts: Perceptronix Medical Inc. Alexei Doudkine, PhD Director of Business Development (604) 629-8785 Email: adoudkine@perceptronix.com
SOURCE: Perceptronix Medical Inc.
Source: MARKET WIRE
Related Articles
- First Day of Ovarian Cancer Symposium Focuses on Early Detection
- Perceptronix Medical Inc.: Early Detection Brings Hope
- BBN Technologies' Stereoscopic Digital Mammography Technology Shows Major Advance In Breast Cancer Screening Through More Accurate Detection of Breast Lesions
- Epigenomics AG: Significant Improvement in Colorectal Cancer Early Detection By DNA Methylation Test Through Modified Assay Procedure; Epigenomics AG Presented Most Recent Data At AACR Annual Meeting 2007
- Biomarkers for Diagnosis and Early Detection of Breast Cancer Highlight Latest Patent Filing By Power3 Medical Products, Inc.
- Cancer Studies Focus on Early Detection
- Power3 Medical to Focus Early-Detection Breast Cancer Tests on Blood Serum
- Monitoring Over-The-Counter Medication Sales for Early Detection of Disease Outbreaks - New York City
- Laura Ingraham's Breast Cancer Highlights Need for Early Detection
- Elizabeth Edwards' Breast Cancer Highlights Need for Early Detection
 |
 |
User Comments (0)
RSS Feeds